Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacological manipulation of the ductus arteriosus.

× No keyword cloud information.

12 in total

1. Lamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2.

Authors: F Coceani; P M Olley; E Bodach
Journal: Prostaglandins Date: 1975-02

2. Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin.

Authors: G J Peckham; O S Miettinen; R C Ellison; E N Kraybill; W M Gersony; S Zierler; A S Nadas
Journal: J Pediatr Date: 1984-08 Impact factor: 4.406

3. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.

Authors: M D Freed; M A Heymann; A B Lewis; S L Roehl; R C Kensey
Journal: Circulation Date: 1981-11 Impact factor: 29.690

4. E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.

Authors: P M Olley; F Coceani; E Bodach
Journal: Circulation Date: 1976-04 Impact factor: 29.690

5. Early administration of indomethacin to preterm infants.

Authors: J M Rennie; J Doyle; R W Cooke
Journal: Arch Dis Child Date: 1986-03 Impact factor: 3.791

6. Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities.

Authors: M A Heymann; W Berman; A M Rudolph; V Whitman
Journal: Circulation Date: 1979-01 Impact factor: 29.690

7. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease.

Authors: A B Lewis; M D Freed; M A Heymann; S L Roehl; R C Kensey
Journal: Circulation Date: 1981-11 Impact factor: 29.690

8. Medical manipulation of the ductus arteriosus.

Authors: R B Elliott; M B Starling; J M Neutze
Journal: Lancet Date: 1975-01-18 Impact factor: 79.321

9. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

Authors: W M Gersony; G J Peckham; R C Ellison; O S Miettinen; A S Nadas
Journal: J Pediatr Date: 1983-06 Impact factor: 4.406

Pharmacological manipulation of the ductus arteriosus.

1. Lamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2.

2. Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin.

3. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.

4. E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.

5. Early administration of indomethacin to preterm infants.

6. Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities.

7. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease.

8. Medical manipulation of the ductus arteriosus.

9. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

10. Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.

Review 1. Congenital heart disease: the ductus arteriosus as pathfinder.

Review 2. The future potential of eicosanoids and their inhibitors in paediatric practice.

3. Effect of infusion rate of indomethacin on cerebrovascular responses in preterm neonates.